Dr. Anna Moore's lab focuses on developing innovative therapies for metastatic breast cancer using nanoparticle-based techniques. They use specially designed nanodrugs to target and inhibit specific microRNAs responsible for cancer cell survival and growth. Through research involving large animal models, the lab aims to translate these promising findings into potential treatment options for human patients.

Dr. Yi Li's lab focuses on understanding brain injuries in newborns who suffer from a lack of oxygen at birth. They use advanced MRI techniques to study how different types of brain damage affect motor skills and language development in infants. The lab aims to improve diagnosis and treatment for these infants by developing better ways to predict their developmental outcomes based on MRI findings.

Dr. Mikhail Y. Berezin's lab at Washington University focuses on understanding how the brain adapts after traumatic peripheral nerve injuries. They use advanced imaging techniques to visualize both nerve regeneration and brain responses in real time, which helps to reveal the relationship between nerve healing and brain plasticity. By studying these interactions, the lab aims to develop better therapies for patients suffering from nerve injuries.

Dr. Warren Grill's lab at Duke University focuses on developing advanced electrical methods to block nerve conduction, especially targeting small nerve fibers involved in pain and autonomic dysfunction. The research aims to optimize electrical waveforms and electrode designs to improve the precision and efficiency of nerve block techniques for clinical applications. This work has potential implications for treating conditions like diabetes, heart failure, and chronic pain management.

David Escobar Sanabria's research lab focuses on understanding Parkinson's disease by exploring how neural circuits in the brain affect movement control. By developing advanced tools that can modulate brain activity in real-time, the lab aims to improve treatments for Parkinson's and other neurological conditions. Specifically, they are investigating how certain brainwave patterns relate to motor symptoms and developing personalized therapeutic devices based on their findings.

Dr. Cameron McIntyre's lab at Duke University focuses on understanding how brain stimulation therapies work by analyzing data and creating computational models. The lab explores the electrical signals recorded from the brain and the effects of stimulating certain areas, aiming to enhance neuromodulation therapies for clinical applications. They use advanced technologies like holographic visualization to support surgical planning for patients receiving deep brain stimulation.

Dr. Karl Deisseroth's lab at Stanford University focuses on understanding how brain states influence neural activity and behavior. By developing advanced imaging and computational techniques, the lab seeks to reveal how different types of neurons interact during various brain states and how these interactions affect sensory perception and behavior. This work is essential for shedding light on the mechanisms behind mental processes and could lead to improved treatments for neurological and psychiatric disorders.

Ellis Meng's lab at the University of Southern California focuses on the development and optimization of flexible neural probe arrays for research in neuroscience. The lab aims to create advanced polymer-based interfaces that can reliably record neural activity across different brain regions in various animal models, including rodents and nonhuman primates. By refining these technologies, the lab seeks to improve the understanding of how neural activity relates to behavior and to promote the widespread use of these innovative tools in neuroscience research.

Dr. Hanwen Zhang's lab at Washington University focuses on improving treatments for neuroblastoma, a challenging pediatric cancer. The research involves developing advanced therapies that combine novel radiopharmaceuticals to better target cancer cells while minimizing harm to surrounding tissues. By exploring high linear energy transfer (LET) agents, the lab aims to enhance treatment efficacy and optimize patient care for children suffering from relapsed neuroblastoma.

Dr. Yi Zhang's lab at the University of Connecticut Storrs focuses on improving our understanding of mental disorders through advanced neurochemical monitoring techniques. By developing a wireless neural probe that can sample multiple neuropeptides and conduct pharmacological stimulation in freely moving animals, the lab aims to uncover the molecular mechanisms that drive various behavioral outputs in the brain. This innovative approach seeks to enhance the precision of neurochemical measurements in real-time, potentially leading to better treatment strategies for mental health conditions.

Professor Reza Kalhor's research lab focuses on understanding how genetic changes affect brain development and lead to conditions like autism. By using advanced genomic techniques, they aim to create detailed maps of how brain cells develop from their early stages. This knowledge could help uncover the origins of developmental disorders and improve public health outcomes.

Dr. Shaoqin Gong's lab at the University of Wisconsin-Madison focuses on developing new treatments for Alzheimer's disease using advanced genetic engineering techniques. They aim to create non-viral nanovectors that can effectively deliver CRISPR genome editing tools across the blood-brain barrier, which is crucial for treating neurodegenerative diseases that affect large areas of the brain. The lab's innovative approach seeks to improve safety and efficiency in gene delivery, potentially leading to new therapeutic options for Alzheimer's patients.

Dr. Nashaat Turkman's lab focuses on developing innovative imaging techniques to study brain disorders, particularly Alzheimer's disease. The lab is working on creating a new type of PET probe that targets a specific enzyme involved in brain health, which could help detect Alzheimer's at earlier stages and track its progression. By combining advanced chemistry and imaging modalities, the research aims to enhance our understanding of neurodegenerative diseases and improve drug targeting strategies.

Dr. Alejandro De La Vega's lab at the University of Texas at Austin focuses on improving how researchers analyze and interpret functional MRI data using advanced artificial intelligence techniques. They are developing tools that automate the extraction of meaningful insights from the massive amount of neuroimaging literature, making it easier for scientists to conduct research and generate new hypotheses about brain function. This work aims to bridge gaps in manual data analysis and enhance the efficiency and accuracy of scientific inquiry in neuroimaging.

The lab led by Qing Wang at Washington University focuses on developing innovative imaging techniques to study neuroinflammation associated with Alzheimer's disease. They are working on a new method called diffusion dictionary imaging (DDI), which uses MRI technology to visualize and quantify neuroinflammation in the brain. This research aims to better understand the relationship between neuroinflammation and the progression of Alzheimer's disease.

Dr. Shella D. Keilholz's lab at Emory University focuses on understanding the dynamic patterns of brain activity using advanced imaging techniques. They study how different types of brain cells communicate and interact during various states of neurological and psychiatric disorders. By integrating wide-field optical imaging with functional MRI, the lab aims to uncover the underlying mechanisms of brain activity patterns, which could ultimately help in diagnosing and treating brain disorders.

Dr. Nikolaos Michael Tsoukias leads a research lab focused on understanding the relationship between neuronal activity and blood flow in the brain. His team investigates how disruptions in this relationship can contribute to cognitive decline and diseases like Alzheimer's. By using experimental models and advanced mathematical simulations, they explore the mechanisms of neurovascular coupling, aiming to find solutions to restore proper brain function and address cognitive impairments.

Dr. Zhengxin Cai's lab focuses on improving the understanding and management of spinal cord injuries (SCI) through advanced imaging techniques. The lab uses a special PET imaging technology to visualize changes in the brain and spinal cord, which may help in diagnosing and tracking the recovery of patients with SCI. Their goal is to provide new insights into neuroplasticity and therapeutic effects, ultimately enhancing patient care and therapy outcomes.

Dr. Anthony Sung's lab at the University of Kansas Medical Center focuses on improving the health of patients with hematologic malignancies by addressing their nutritional needs. Through a project called NOURISH, the lab partners with food banks to deliver tailored food assistance directly to patients in a clinical setting, which aims to combat malnutrition associated with cancer treatments. This innovative approach not only enhances patient care but also explores cost-effective solutions for healthcare systems.

Dr. Brian O Diekman's lab studies the effects of DNA damage and cellular aging on osteoarthritis, a common joint disease. They focus on understanding how these factors lead to cell senescence, inflammation, and joint degeneration to develop better treatments. The lab uses advanced techniques to assess the extent of DNA damage and its effects on joint cells, aiming to spark new strategies to prevent and treat osteoarthritis.